C-reactive protein and other inflammatory risk markers in acute coronary syndromes (Q28195425)

Journal of the American College of Cardiology

Europe PubMed Central

title

C-reactive protein and other inflammatory risk markers in acute coronary syndromes (English)

0 references

main subject

inflammation

0 references

acute coronary syndrome

1 reference

2

Paul M Ridker

0 references

author name string

Gavin J Blake

series ordinal

1

0 references

language of work or name

English

0 references

publication date

19 February 2003

0 references

published in

0 references

volume

41

0 references

issue

4 Suppl S

0 references

page(s)

37S-42S

0 references

cites work

ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the M

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. PRISM Study Investigators. Platelet Receptor Inhibition in Ischemic Syndrome Management

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial Ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

Novel clinical markers of vascular wall inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

Direct proinflammatory effect of C-reactive protein on human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

Generation of C-reactive protein and complement components in atherosclerotic plaques

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

C-reactive protein, fibrin D-dimer, and incident ischemic heart disease in the Speedwell study: are inflammation and fibrin turnover linked in pathogenesis?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

Inflammation and long-term mortality after non-ST elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

Enhanced Inflammatory Response to Coronary Angioplasty in Patients With Severe Unstable Angina

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

Increasing Levels of Interleukin (IL)-1Ra and IL-6 During the First 2 Days of Hospitalization in Unstable Angina Are Associated With Increased Risk of In-Hospital Coronary Events

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

A prospective evaluation of lipoprotein-associated phospholipase A(2) levels and the risk of future cardiovascular events in women

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

Association between myeloperoxidase levels and risk of coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

Pregnancy-associated plasma protein A as a marker of acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

Inflammatory markers in coronary artery disease: let prevention douse the flames

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

Evaluating novel cardiovascular risk factors: can we better predict heart attacks?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

Locking a leukocyte integrin with statins

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

Rapid reduction in C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

Projected life-expectancy gains with statin therapy for individuals with elevated C-reactive protein levels

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations: a placebo-controlled study using a highly sensitive C-reactive protein assay

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902953-4

7 January 2021

10.1016/S0735-1097(02)02953-4

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

12644339

1 reference

Consolidated OpenCitations Corpus – April 2017